Canaccord Genuity Reiterate Buy Following Workday (WDAY) Q1
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
Go back to Canaccord Genuity Reiterate Buy Following Workday (WDAY) Q1
May 27, 2015 7:04 AM EDT
Cowen maintains an Outperform rating on Workday (NYSE: WDAY), and cuts the price target to $101.00 (from $111.00), following Q1 results. WDAY reported Q1 revenue of $251m, compared to consensus estimates of $245m. Billings were reported at $271.6m vs. $261m consensus. Workday... More
May 26, 2015 6:04 PM EDT
Emerald Oil (NYSE: EOX) 53.6% HIGHER; elected not to proceed with its previously announced public offering of common stock. As a result of the Company's election not to proceed with its public offering, the Company will not be taking action to close the previously announced Delaware Basin acquisition.
Five Prime Therapeutics, Inc. (Nasdaq: FPRX) 20.2% HIGHER; bluebird bio (NASDAQ: BLUE) and Five Prime Therapeutics, Inc. (Nasdaq: FPRX) announced that they... More
May 26, 2015 4:05 PM EDT
Workday, Inc. (NYSE: WDAY) reported Q1 EPS of ($0.02), $0.06 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $251 million versus the consensus estimate of $245.01 million.
Workday, Inc. sees Q2 2015 revenue of $270-274 million, versus the consensus of $272.39 million.
For... More
